1. Home
  2. RELL vs LCTX Comparison

RELL vs LCTX Comparison

Compare RELL & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richardson Electronics Ltd.

RELL

Richardson Electronics Ltd.

HOLD

Current Price

$17.71

Market Cap

248.1M

Sector

Technology

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

301.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELL
LCTX
Founded
1947
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.1M
301.7M
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
RELL
LCTX
Price
$17.71
$1.11
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
156.3K
816.9K
Earning Date
04-08-2026
05-14-2026
Dividend Yield
1.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$228,564,000.00
$14,556,000.00
Revenue This Year
$6.32
$109.40
Revenue Next Year
$7.91
N/A
P/E Ratio
$230.96
N/A
Revenue Growth
9.41
53.24
52 Week Low
$9.37
$1.00
52 Week High
$23.15
$2.09

Technical Indicators

Market Signals
Indicator
RELL
LCTX
Relative Strength Index (RSI) 47.89 50.78
Support Level $16.45 $1.02
Resistance Level $17.94 $1.18
Average True Range (ATR) 0.78 0.05
MACD -0.09 0.00
Stochastic Oscillator 47.75 51.72

Price Performance

Historical Comparison
RELL
LCTX

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd is a world-wide manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions. It serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. Its products and services include design-in support, systems integration, prototype design and manufacturing, testing, logistics, etc. Its segments are Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. Majority of Sales is from PMT. Majority of sales is from North America.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: